| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 21.883 | 28.678 | 26.526 | 21.096 | 22.310 | 21.731 | 22.382 | 31.124 | 29.220 | 36.496 |
| Total Income - EUR | 23.246 | 29.111 | 26.526 | 21.096 | 22.310 | 22.329 | 22.382 | 31.124 | 29.220 | 36.606 |
| Total Expenses - EUR | 22.470 | 28.227 | 20.770 | 20.526 | 20.341 | 13.789 | 21.781 | 29.551 | 24.720 | 35.168 |
| Gross Profit/Loss - EUR | 776 | 884 | 5.756 | 571 | 1.969 | 8.540 | 601 | 1.573 | 4.500 | 1.439 |
| Net Profit/Loss - EUR | 121 | 593 | 4.992 | 360 | 1.746 | 8.395 | 377 | 1.262 | 4.208 | 341 |
| Employees | 4 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Corla Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 19.561 | 12.627 | 7.229 | 3.020 | 0 | 0 | 94.539 | 90.091 | 85.090 | 79.914 |
| Current Assets | 2.281 | 2.680 | 1.942 | 1.949 | 33.007 | 34.937 | 7.775 | 4.287 | 13.749 | 12.421 |
| Inventories | 1.539 | 905 | 1.516 | 1.683 | 1.437 | 2.026 | 2.247 | 2.538 | 3.634 | 3.363 |
| Receivables | 106 | 0 | 35 | 16 | 29.110 | 19.116 | 821 | 500 | 498 | 501 |
| Cash | 636 | 1.775 | 391 | 249 | 2.460 | 13.796 | 4.707 | 1.249 | 9.616 | 8.557 |
| Shareholders Funds | 3.094 | 3.655 | 1.672 | 2.000 | 3.707 | 12.133 | 12.241 | 77.112 | 81.086 | 80.973 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 63.611 | 63.419 | 63.064 |
| Debts | 18.749 | 11.653 | 7.499 | 2.968 | 29.299 | 22.805 | 90.073 | 17.266 | 17.753 | 11.362 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Corla Med S.r.l.